
About Valiant Organics
Valiant Organics is a publicly listed company based in Mumbai (India) founded in 2005. Manufacturer and supplier of diversified chemicals. The company has 965 employees. Its Indian entity Valiant Organics Limited reported revenue of βΉ751 Cr. Valiant Organics offers products and services including Chloro Phenols, Ammonolysis Products, and Acetylation Products. Its focus areas include Chemicals and Materials, Diversified Chemicals and Speciality Chemicals.
Company details
Valiant Organics, established in 2005 and currently in Public stage, focuses on chemicals and materials, diversified chemicals, and speciality chemicals. Manufacturer and supplier of diversified chemicals. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- Employees 965
- Stage Public
- SectorsChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website valiantorganics.com
- Social LinkedIn
- Legal Name Valiant Organics Limited
- Market Cap₹953 Cr
VALIANTORG · NSE
- Share Price₹323.15
-4.98% today
- Revenue₹739 Cr
FY 2025-26 · +2.8% YoY
- EBITDA₹87.06 Cr
Margin 11.8%
- Net Profit₹25.98 Cr
FY 2025-26 · +400.0% YoY
- P/E (TTM)15.5x
P/B 1.2x
- ROE3.5%
ROCE 5.4%
- Debt / Equity0.34
Interest cover 38.3x
- Employee Count965
Associated legal entities of Valiant Organics
Valiant Organics is associated with 2 registered companies on The Company Check; the primary company is Valiant Organics Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Valiant Organics Limited Listed CIN L24230MH2005PLC151348 | Active | 16 Feb 2005 | Mumbai, Maharashtra | ₹751 Cr | 968 | 13 | View details |
| Valiant Speciality Chemical Limited CIN U24230GJ2019PLC111566 | Active | 20 Dec 2019 | Sarigam, Gujarat | ₹0.0 Cr | 3 | View details |
Products & Services of Valiant Organics
Valiant Organics offers a comprehensive portfolio of products and services, including Chloro Phenols, Ammonolysis Products, and Acetylation Products.
Chemicals produced for industrial applications in various sectors
Derived from ammonolysis for use in dyes and pharmaceuticals
Products for cosmetics and polymer industries
Board of directors of Valiant Organics Limited (Valiant Organics)
Valiant Organics Limited is the primary company behind Valiant Organics. The boards of the 2 registered companies of Valiant Organics currently have 11 directors; the longest-serving is Mahek Chheda Manoj, appointed in 2019. 25 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mahek Chheda Manoj DIN 06763870 | Director | 20 Dec 2019 | 6 yrs 11 mo | Valiant Speciality Chemical Limited, Valiant Organics Limited |
| Kiritkumar Haribhai Desai DIN 08610595 | Director | 14 Aug 2021 | 5 yrs 3 mo | Valiant Organics Limited |
| Nemin Mahesh Savadia DIN 00128256 | Whole-time director | 01 May 2022 | 4 yrs 6 mo | Valiant Organics Limited |
| Santosh Shantilal Vora DIN 07633923 | Director | 01 May 2022 | 4 yrs 6 mo | Valiant Organics Limited |
| Sathiababu Krishnan Kallada DIN 02107652 | Director | 23 May 2022 | 4 yrs 5 mo | Valiant Speciality Chemical Limited, Valiant Organics Limited |
| Sidhharth Dinesh Shah DIN 07263018 | Whole-time director | 01 Jun 2022 | 4 yrs 5 mo | Valiant Organics Limited |
| Sonal Amit Vira DIN 09505883 | Director | 04 Aug 2022 | 4 yrs 3 mo | Valiant Organics Limited |
| Navin Chapshi Shah DIN 01415556 | Director | 04 Aug 2022 | 4 yrs 3 mo | Valiant Organics Limited |
| Sudhirprakash Baburao Sawant DIN 02343218 | Director | 19 May 2023 | 3 yrs 6 mo | Valiant Organics Limited |
| Parimal Hasmukhlal Desai DIN 00009272 | Director | 26 Sep 2024 | 2 yrs 1 mo | Valiant Speciality Chemical Limited, Valiant Organics Limited |
| Paras Sumtichandra Savla DIN 10773507 | Director | 13 Nov 2024 | 2 yrs | Valiant Organics Limited |
People of Valiant Organics
1 people are tracked at Valiant Organics (1 in leadership); the tracked headcount is 965.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for Valiant Organics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Valiant Organics
Valiant Organics is a publicly listed company on the NSE with ticker symbol VALIANTORG in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date14 Oct 2016
- Listed onBSE: 540145 · NSE: VALIANTORG
- Listed entityValiant Organics Limited
- Exchange sectorProcess industries
- ISININE565V01010
- Share price₹462.90 (+2.39% on the day) · 2026-10-14
- Market capitalisation₹1,270 Cr
- Price to earnings24.0
- EPS (diluted, trailing year)₹19.30
- Volume (last session)42,031
Financials of Valiant Organics
Exchange-reported figures of Valiant Organics Limited, the listed company behind Valiant Organics (NSE: VALIANTORG).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 739 | 719 | 723 | 1,052 | 1,153 | 755 | 675 |
| Revenue growth | +2.8% | -0.6% | -31.3% | -8.8% | +52.8% | +11.8% | - |
| EBITDA | 87.06 | 53.18 | 33.26 | 164 | 205 | 205 | 181 |
| EBITDA margin | +11.8% | +7.4% | +4.6% | +15.6% | +17.8% | +27.2% | +26.7% |
| Profit before tax | 41.93 | 2.15 | (8.70) | 137 | 176 | 185 | 168 |
| Net profit | 25.98 | (8.66) | (6.44) | 84.37 | 113 | 115 | 124 |
| Net profit margin | +3.5% | -1.2% | -0.9% | +8.0% | +9.8% | +15.2% | +18.4% |
| EPS (βΉ) | 11.86 | (1.33) | (3.04) | 32.45 | 41.72 | 42.19 | 102.00 |
| Balance sheet | |||||||
| Total assets | 1,036 | 978 | 990 | 1,015 | 1,013 | 718 | 539 |
| Net worth | 759 | 725 | 729 | 689 | 613 | 502 | 388 |
| Total debt | 256 | 249 | 257 | 274 | 363 | 209 | 138 |
| Cash & bank | 2.14 | 7.65 | 3.80 | 8.15 | 45.38 | 30.98 | 12.68 |
| Net working capital | 203 | 185 | 180 | 243 | 370 | 161 | 105 |
| Cash flow | |||||||
| Cash from operations | 91.99 | 56.43 | 84.00 | 238 | (30.75) | 113 | 161 |
| Cash from investing | (86.22) | (20.96) | (65.19) | (143) | (124) | (156) | (184) |
| Cash from financing | (11.07) | (31.81) | (23.12) | (112) | 167 | 48.64 | 27.16 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 304 | 232 | 218 | 159 | 157 | 204 | 204 | 187 |
| Revenue growth (YoY) | +93.4% | +13.3% | +6.9% | -14.8% | -1.8% | +21.7% | - | - |
| Other income | 1.25 | 10.51 | 4.62 | 7.36 | 0.27 | 1.70 | 0.91 | 5.85 |
| EBITDA | 39.02 | 41.62 | 26.49 | 13.21 | 21.16 | 24.87 | 20.69 | 15.32 |
| EBITDA margin | +12.8% | +18.0% | +12.2% | +8.3% | +13.5% | +12.2% | +10.2% | +8.2% |
| Depreciation | 10.31 | 10.22 | 10.25 | 10.11 | 9.78 | 9.42 | 9.20 | 8.99 |
| Interest | 5.18 | 5.13 | 3.30 | 4.60 | 4.21 | 6.05 | 5.07 | 5.83 |
| Profit before tax | 24.78 | 36.78 | 17.56 | 5.86 | 7.44 | 11.10 | 7.33 | 6.35 |
| Tax | 7.49 | 7.51 | 1.83 | 2.20 | 1.76 | 2.90 | 3.14 | 0.89 |
| Net profit | 17.29 | 29.27 | 15.73 | 3.66 | 5.68 | 8.20 | 4.19 | 5.46 |
| EPS (βΉ) | 6.18 | 10.44 | 5.61 | 1.30 | 2.02 | 2.93 | 1.52 | 1.01 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 738 | 719 | 677 | 912 | 948 | 574 | 584 |
| Revenue growth | +2.7% | +6.1% | -25.7% | -3.9% | +65.2% | -1.6% | - |
| EBITDA | 88.20 | 53.97 | 39.54 | 130 | 167 | 157 | 174 |
| EBITDA margin | +12.0% | +7.5% | +5.8% | +14.3% | +17.6% | +27.4% | +29.8% |
| Profit before tax | 43.07 | 2.41 | (5.13) | 99.64 | 137 | 152 | 165 |
| Net profit | 27.17 | (5.76) | (7.58) | 71.88 | 101 | 115 | 124 |
| Net profit margin | +3.7% | -0.8% | -1.1% | +7.9% | +10.7% | +20.0% | +21.2% |
| EPS (βΉ) | 12.26 | (1.07) | (1.10) | 27.83 | 37.91 | 42.20 | 102.00 |
| Balance sheet | |||||||
| Total assets | 936 | 877 | 884 | 887 | 909 | 653 | 505 |
| Net worth | 697 | 662 | 665 | 666 | 603 | 502 | 388 |
| Total debt | 219 | 212 | 216 | 220 | 305 | 149 | 117 |
| Cash & bank | 1.63 | 7.43 | 3.57 | 6.58 | 23.30 | 11.78 | 10.58 |
| Net working capital | 202 | 136 | 131 | 177 | 257 | 92.79 | 79.47 |
| Cash flow | |||||||
| Cash from operations | 44.29 | 58.56 | 85.09 | 183 | (11.17) | 115 | 160 |
| Cash from investing | (38.90) | (27.06) | (65.03) | (90.63) | (120) | (135) | (191) |
| Cash from financing | (11.17) | (27.65) | (23.12) | (109) | 146 | 21.89 | 35.43 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 304 | 232 | 218 | 159 | 157 | 204 | 204 | 187 |
| Revenue growth (YoY) | +93.5% | +13.3% | +6.8% | -14.9% | -1.9% | +21.7% | - | - |
| Other income | 1.11 | 2.64 | 4.01 | 7.36 | 0.20 | 1.07 | 0.67 | 5.04 |
| Total expenses | 265 | 190 | 191 | 143 | 136 | 180 | 183 | 172 |
| EBITDA | 39.02 | 41.63 | 26.49 | 15.62 | 21.16 | 24.88 | 20.71 | 15.33 |
| EBITDA margin | +12.8% | +18.0% | +12.2% | +9.8% | +13.5% | +12.2% | +10.2% | +8.2% |
| Depreciation | 10.31 | 10.22 | 10.25 | 10.11 | 9.78 | 9.42 | 9.20 | 8.99 |
| Interest | 5.18 | 5.13 | 3.30 | 4.60 | 4.21 | 6.05 | 5.07 | 5.83 |
| Profit before tax | 24.64 | 28.92 | 16.95 | 8.27 | 7.37 | 10.48 | 7.11 | 5.55 |
| Tax | 7.49 | 7.09 | 1.83 | 2.20 | 1.76 | 2.90 | 3.15 | 0.91 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 304 | 232 | 218 | 159 | 157 | 204 | 204 | 187 |
| Revenue growth (YoY) | +93.4% | +13.3% | +6.9% | -14.8% | -1.8% | +21.7% | - | - |
| Other income | 1.25 | 10.51 | 4.62 | 7.36 | 0.27 | 1.70 | 0.91 | 5.85 |
| EBITDA | 39.02 | 41.62 | 26.49 | 13.21 | 21.16 | 24.87 | 20.69 | 15.32 |
| EBITDA margin | +12.8% | +18.0% | +12.2% | +8.3% | +13.5% | +12.2% | +10.2% | +8.2% |
| Depreciation | 10.31 | 10.22 | 10.25 | 10.11 | 9.78 | 9.42 | 9.20 | 8.99 |
| Interest | 5.18 | 5.13 | 3.30 | 4.60 | 4.21 | 6.05 | 5.07 | 5.83 |
| Profit before tax | 24.78 | 36.78 | 17.56 | 5.86 | 7.44 | 11.10 | 7.33 | 6.35 |
| Tax | 7.49 | 7.51 | 1.83 | 2.20 | 1.76 | 2.90 | 3.14 | 0.89 |
| Net profit | 17.29 | 29.27 | 15.73 | 3.66 | 5.68 | 8.20 | 4.19 | 5.46 |
| EPS (βΉ) | 6.18 | 10.44 | 5.61 | 1.30 | 2.02 | 2.93 | 1.52 | 1.01 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 739 | 719 | 723 | 1,052 | 1,153 | 755 | 675 |
| Revenue growth | +2.8% | -0.6% | -31.3% | -8.8% | +52.8% | +11.8% | - |
| Other income | 12.64 | 8.78 | 9.30 | 12.93 | 7.42 | 5.94 | 6.30 |
| Total expenses | 652 | 666 | 690 | 888 | 948 | 549 | 494 |
| Employee cost | 48.86 | 44.99 | 49.35 | 46.33 | 37.16 | 29.40 | 22.78 |
| EBITDA | 87.06 | 53.18 | 33.26 | 164 | 205 | 205 | 181 |
| EBITDA margin | +11.8% | +7.4% | +4.6% | +15.6% | +17.8% | +27.2% | +26.7% |
| Depreciation | 39.57 | 35.76 | 34.92 | 29.19 | 29.62 | 21.24 | 15.77 |
| Interest | 18.20 | 24.05 | 16.34 | 10.79 | 6.48 | 5.20 | 2.57 |
| Profit before tax | 41.93 | 2.15 | (8.70) | 137 | 176 | 185 | 168 |
| Tax | 8.71 | 5.58 | (0.29) | 34.61 | 48.26 | 53.99 | 42.29 |
| Net profit | 25.98 | (8.66) | (6.44) | 84.37 | 113 | 115 | 124 |
| Net profit margin | +3.5% | -1.2% | -0.9% | +8.0% | +9.8% | +15.2% | +18.4% |
| EPS (βΉ) | 11.86 | (1.33) | (3.04) | 32.45 | 41.72 | 42.19 | 102.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 28.02 | 28.00 | 27.58 | 27.56 | 27.56 | 27.56 | 13.98 |
| Reserves & surplus | 731 | 697 | 702 | 662 | 586 | 475 | 374 |
| Shareholders' funds (net worth) | 759 | 725 | 729 | 689 | 613 | 502 | 388 |
| Minority interest | (0.01) | 0.00 | 0.00 | 50.89 | 35.75 | 6.30 | 13.13 |
| Secured loans | 185 | 190 | 180 | 219 | 308 | 126 | 105 |
| Unsecured loans | 71.04 | 58.86 | 76.77 | 54.89 | 55.79 | 82.81 | 33.01 |
| Total debt | 256 | 249 | 257 | 274 | 363 | 209 | 138 |
| Total liabilities | 1,036 | 978 | 990 | 1,015 | 1,013 | 718 | 539 |
| Assets | |||||||
| Gross block | 925 | 847 | 800 | 815 | 656 | 625 | 371 |
| Net block | 695 | 657 | 643 | 670 | 543 | 510 | 276 |
| Capital work in progress | 21.16 | 65.70 | 86.14 | 70.88 | 112 | 45.89 | 129 |
| Investments | 151 | 93.58 | 98.60 | 41.19 | 7.81 | 6.34 | 22.85 |
| Inventories | 92.62 | 88.97 | 114 | 126 | 114 | 72.17 | 44.86 |
| Sundry debtors | 243 | 177 | 209 | 254 | 321 | 157 | 133 |
| Cash & bank balances | 2.14 | 7.65 | 3.80 | 8.15 | 45.38 | 30.98 | 12.68 |
| Loans & advances | 15.25 | 82.56 | 81.98 | 44.85 | 42.40 | 38.85 | 29.15 |
| Total current assets | 353 | 356 | 409 | 434 | 522 | 299 | 219 |
| Total current liabilities | 151 | 171 | 229 | 191 | 152 | 137 | 115 |
| Net working capital | 203 | 185 | 180 | 243 | 370 | 161 | 105 |
| Total assets | 1,036 | 978 | 990 | 1,015 | 1,013 | 718 | 539 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 7.10 | 3.44 | 7.75 | 25.05 | 12.83 | 7.66 | 2.86 |
| Net cash from operating activities | 91.99 | 56.43 | 84.00 | 238 | (30.75) | 113 | 161 |
| Net cash from investing activities | (86.22) | (20.96) | (65.19) | (143) | (124) | (156) | (184) |
| Net cash from financing activities | (11.07) | (31.81) | (23.12) | (112) | 167 | 48.64 | 27.16 |
| Net change in cash | (5.30) | 3.66 | (4.31) | (17.30) | 12.21 | 5.18 | 4.80 |
| Closing cash | 2.14 | 7.65 | 3.80 | 8.15 | 45.38 | 30.98 | 12.68 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +2.8% | -0.6% | -31.3% | -8.8% | +52.8% | +11.8% | - |
| EBITDA growth | +63.7% | +59.9% | -79.8% | -19.8% | -0.3% | +13.8% | - |
| PBT growth | +1850.2% | +9998.0% | - | -22.1% | -4.7% | +9.7% | -1.6% |
| Net income growth | +400.0% | -34.5% | -107.6% | -25.5% | -1.1% | -7.6% | - |
| Revenue CAGR (3Y) | -11.1% | -14.6% | -1.4% | +15.9% | +18.5% | - | - |
| EBITDA CAGR (3Y) | -19.1% | -36.2% | -45.5% | -3.1% | +4.4% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +4.5% | -0.5% | -1.2% | +9.8% | +11.1% | +17.3% | +18.7% |
| Return on capital employed | +5.4% | +2.5% | +1.1% | +15.2% | +21.6% | +30.7% | +39.5% |
| Return on net worth | +3.5% | -1.2% | -0.9% | +15.8% | +23.0% | +29.5% | +39.1% |
| Debt / equity | 0.34 | 0.35 | 0.37 | 0.49 | 0.51 | 0.39 | 0.33 |
| Long-term debt / equity | 0.07 | 0.09 | 0.10 | 0.14 | 0.16 | 0.18 | 0.20 |
| Interest cover | 38.32 | 138.06 | -984.34 | 7.99 | 3.70 | 2.82 | 1.56 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.83 | 0.87 | 0.90 | 1.43 | 1.83 | 1.51 | 2.25 |
| Inventory turnover | 8.14 | 7.07 | 6.01 | 8.77 | 12.41 | 12.90 | 14.55 |
| Debtors turnover | 3.52 | 3.72 | 3.12 | 3.66 | 4.83 | 5.22 | 4.93 |
| EPS (βΉ) | 11.86 | (1.33) | (3.04) | 32.45 | 41.72 | 42.19 | 102.00 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 1.00 | 3.50 | 5.00 | 11.00 |
| Book value per share (βΉ) | 271.02 | 258.98 | 264.48 | 253.66 | 225.66 | 184.83 | 317.50 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 304 | 232 | 218 | 159 | 157 | 204 | 204 | 187 |
| Revenue growth (YoY) | +93.5% | +13.3% | +6.8% | -14.9% | -1.9% | +21.7% | - | - |
| Other income | 1.11 | 2.64 | 4.01 | 7.36 | 0.20 | 1.07 | 0.67 | 5.04 |
| Total expenses | 265 | 190 | 191 | 143 | 136 | 180 | 183 | 172 |
| EBITDA | 39.02 | 41.63 | 26.49 | 15.62 | 21.16 | 24.88 | 20.71 | 15.33 |
| EBITDA margin | +12.8% | +18.0% | +12.2% | +9.8% | +13.5% | +12.2% | +10.2% | +8.2% |
| Depreciation | 10.31 | 10.22 | 10.25 | 10.11 | 9.78 | 9.42 | 9.20 | 8.99 |
| Interest | 5.18 | 5.13 | 3.30 | 4.60 | 4.21 | 6.05 | 5.07 | 5.83 |
| Profit before tax | 24.64 | 28.92 | 16.95 | 8.27 | 7.37 | 10.48 | 7.11 | 5.55 |
| Tax | 7.49 | 7.09 | 1.83 | 2.20 | 1.76 | 2.90 | 3.15 | 0.91 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 738 | 719 | 677 | 912 | 948 | 574 | 584 |
| Revenue growth | +2.7% | +6.1% | -25.7% | -3.9% | +65.2% | -1.6% | - |
| Other income | 12.64 | 8.25 | 8.68 | 7.80 | 3.31 | 16.90 | 5.21 |
| Total expenses | 650 | 665 | 638 | 782 | 781 | 417 | 410 |
| Employee cost | 48.86 | 44.99 | 47.50 | 41.81 | 34.07 | 26.68 | 20.49 |
| EBITDA | 88.20 | 53.97 | 39.54 | 130 | 167 | 157 | 174 |
| EBITDA margin | +12.0% | +7.5% | +5.8% | +14.3% | +17.6% | +27.4% | +29.8% |
| Depreciation | 39.57 | 35.76 | 33.97 | 27.63 | 27.29 | 18.63 | 13.04 |
| Interest | 18.20 | 24.05 | 19.38 | 10.54 | 6.35 | 3.49 | 1.29 |
| Profit before tax | 43.07 | 2.41 | (5.13) | 99.64 | 137 | 152 | 165 |
| Tax | 8.71 | 5.41 | (2.09) | 24.06 | 34.01 | 37.45 | 40.61 |
| Net profit | 27.17 | (5.76) | (7.58) | 71.88 | 101 | 115 | 124 |
| Net profit margin | +3.7% | -0.8% | -1.1% | +7.9% | +10.7% | +20.0% | +21.2% |
| EPS (βΉ) | 12.26 | (1.07) | (1.10) | 27.83 | 37.91 | 42.20 | 102.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 28.02 | 28.00 | 27.58 | 27.56 | 27.56 | 27.56 | 13.98 |
| Reserves & surplus | 669 | 634 | 637 | 638 | 576 | 475 | 374 |
| Shareholders' funds (net worth) | 697 | 662 | 665 | 666 | 603 | 502 | 388 |
| Secured loans | 216 | 211 | 215 | 219 | 270 | 125 | 101 |
| Unsecured loans | 3.15 | 0.32 | 0.55 | 0.44 | 35.40 | 23.73 | 15.29 |
| Total debt | 219 | 212 | 216 | 220 | 305 | 149 | 117 |
| Total liabilities | 936 | 877 | 884 | 887 | 909 | 653 | 505 |
| Assets | |||||||
| Gross block | 912 | 835 | 788 | 734 | 605 | 558 | 338 |
| Net block | 683 | 644 | 630 | 610 | 509 | 478 | 256 |
| Capital work in progress | 21.16 | 65.70 | 86.14 | 70.20 | 110 | 45.89 | 129 |
| Investments | 63.54 | 54.08 | 54.17 | 52.80 | 53.49 | 41.97 | 33.82 |
| Inventories | 92.62 | 88.97 | 114 | 114 | 97.34 | 66.03 | 40.93 |
| Sundry debtors | 243 | 174 | 209 | 212 | 253 | 117 | 111 |
| Cash & bank balances | 1.63 | 7.43 | 3.57 | 6.58 | 23.30 | 11.78 | 10.58 |
| Loans & advances | 15.16 | 33.65 | 33.27 | 31.16 | 30.19 | 31.17 | 27.27 |
| Total current assets | 353 | 304 | 360 | 363 | 404 | 226 | 190 |
| Total current liabilities | 150 | 168 | 229 | 186 | 147 | 133 | 110 |
| Net working capital | 202 | 136 | 131 | 177 | 257 | 92.79 | 79.47 |
| Total assets | 936 | 877 | 884 | 887 | 909 | 653 | 505 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 7.06 | 3.21 | 6.26 | 22.97 | 8.63 | 7.55 | 2.73 |
| Net cash from operating activities | 44.29 | 58.56 | 85.09 | 183 | (11.17) | 115 | 160 |
| Net cash from investing activities | (38.90) | (27.06) | (65.03) | (90.63) | (120) | (135) | (191) |
| Net cash from financing activities | (11.17) | (27.65) | (23.12) | (109) | 146 | 21.89 | 35.43 |
| Net change in cash | (5.78) | 3.85 | (3.05) | (16.70) | 14.34 | 1.08 | 4.82 |
| Closing cash | 1.63 | 7.43 | 3.57 | 6.58 | 23.30 | 11.78 | 10.58 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +2.7% | +6.1% | -25.7% | -3.9% | +65.2% | -1.6% | - |
| EBITDA growth | +63.4% | +36.5% | -69.6% | -22.3% | +6.4% | -9.4% | - |
| PBT growth | +1687.1% | +9998.0% | - | -27.3% | -9.9% | -7.6% | -3.7% |
| Net income growth | +571.7% | +24.0% | -110.6% | -29.0% | -11.6% | -7.5% | - |
| Revenue CAGR (3Y) | -6.8% | -8.8% | +5.7% | +16.0% | +16.1% | +68.2% | +99.6% |
| EBITDA CAGR (3Y) | -12.1% | -31.4% | -36.9% | -9.2% | -2.1% | +81.3% | +111.4% |
| Profitability & leverage | |||||||
| Net income margin | +4.7% | -0.4% | -0.5% | +8.3% | +10.9% | +20.0% | +21.2% |
| Return on capital employed | +6.1% | +2.9% | +1.0% | +12.3% | +18.3% | +26.9% | +40.5% |
| Return on net worth | +4.0% | -0.9% | -1.1% | +11.9% | +18.6% | +25.8% | +38.4% |
| Debt / equity | 0.32 | 0.32 | 0.33 | 0.41 | 0.41 | 0.30 | 0.26 |
| Long-term debt / equity | 0.08 | 0.09 | 0.10 | 0.12 | 0.15 | 0.18 | 0.19 |
| Interest cover | 37.43 | 132.07 | 347.94 | 10.29 | 4.54 | 2.52 | 0.80 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.85 | 0.89 | 0.89 | 1.36 | 1.63 | 1.28 | 2.17 |
| Inventory turnover | 8.13 | 7.07 | 5.94 | 8.64 | 11.61 | 10.74 | 14.62 |
| Debtors turnover | 3.54 | 3.75 | 3.22 | 3.92 | 5.13 | 5.05 | 5.04 |
| EPS (βΉ) | 12.26 | (1.07) | (1.10) | 27.83 | 37.91 | 42.20 | 102.00 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 1.00 | 3.50 | 5.00 | 11.00 |
| Book value per share (βΉ) | 248.70 | 236.25 | 241.12 | 245.14 | 221.97 | 184.84 | 317.50 |
Web traffic of Valiant Organics
The website of Valiant Organics (valiantorganics.com) receives about 2K visits a month.
- Monthly visits2K
▲ 1% vs previous month
Websites whose visitors overlap most with Valiant Organics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| marketsmojo.com | 100% | 834.5K | #72,195 | View details |
Top companies in Core & Diversified Chemicals
3 companies that operate in the same segment as Valiant Organics (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate | 1979 | Pune, Maharashtra, India | USD 1.21 B | 1,020 | ||
Specialty chemicals are manufactured through integrated R&D and production processes. | 2023 | Bengaluru, Karnataka, India | USD 72.97 M | USD 23.86 M | ||
Manufactures coal tar and basic industrial chemicals. | 1987 | Kolkata, West Bengal, India | USD 24 M | USD 515.01 M | 1,161 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Valiant Organics
Complete news archive for Valiant Organics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valiant Organics
Valiant Organics was founded in 2005.
Valiant Organics is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Valiant Organics has 965 employees.
The primary company behind Valiant Organics, Valiant Organics Limited, reported revenue of βΉ751 Cr for FY 2026, up 3% year on year.
Valiant Organics, established in 2005 and currently in Public stage, focuses on chemicals and materials, diversified chemicals, and speciality chemicals. Manufacturer and supplier of diversified chemicals. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
Valiant Organics offers Chloro Phenols, Ammonolysis Products, and Acetylation Products.
Yes, Valiant Organics is publicly traded on NSE under the ticker symbol VALIANTORG.
Valiant Organics is associated with 2 legal entities: Valiant Organics Limited, Valiant Speciality Chemical Limited.
The legal entities of Valiant Organics currently have 13 directors, including Parimal Hasmukhlal Desai, Sathiababu Krishnan Kallada, Mahek Chheda Manoj and others.
